Molecular recognition in the protein C anticoagulant pathway

被引:59
作者
Dahlbäck, B
Villoutreix, BO
机构
[1] Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Dept Lab Med,Div Clin Chem, S-20502 Malmo, Sweden
[2] Univ Paris 05, INSERM U, Paris, France
关键词
factor V; protein C; protein S; thrombomodulin;
D O I
10.1046/j.1538-7836.2003.00299.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The protein C (PC) anticoagulant system provides specific and efficient control of blood coagulation. The system comprises circulating or membrane-bound protein components that take part in complicated multimolecular protein complexes being assembled on specific cellular phospholipid membranes. Each of the participating proteins is composed of multiple domains, many of which are known at the level of their three-dimensional structures. The key component of the PC system. the vitamin K-dependent PC, circulates in blood as zymogen to an anticoagulant serine protease. Activation is achieved on the Surface of endothelial cells by thrombin bound to the membrane protein thrombomodulin. The endothelial PC receptor binds the Gla domain of PC and stimulates the activation. Activated PC (APC) modulates the activity of blood coagulation by specific proteolytic cleavages of a limited number of peptide bonds in factor (F)VIIIa and FVa, cofactors in the activation of FX and prothrombin, respectively. These reactions occur on the surface of negatively charged phospholipid membranes and are Stimulated by the vitamin K-dependent protein S. Regulation of FVIIIa activity by APC is stimulated not only by protein S but also by FV, which, like thrombin, is a Janus-faced protein with both pro- and anticoagulant potential. However, whereas the properties of thrombin are modulated by protein-protein interactions, the specificity of FV function is governed by proteolysis by pro- or anti-coagulant enzymes. The molecular recognition of the PC system is beginning to be unravelled and provides insights into a fascinating and intricate molecular scenario.
引用
收藏
页码:1525 / 1534
页数:10
相关论文
共 93 条
[51]   PEPTIDE-BOND CLEAVAGES AND LOSS OF FUNCTIONAL-ACTIVITY DURING INACTIVATION OF FACTOR VA AND FACTOR VA(R506Q) BY ACTIVATED PROTEIN-C [J].
NICOLAES, GAF ;
TANS, G ;
THOMASSEN, MCLGD ;
HEMKER, HC ;
PABINGER, I ;
VARADI, K ;
SCHWARZ, HP ;
ROSING, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :21158-21166
[52]   Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex [J].
Nicolaes, GAF ;
Villoutreix, BO ;
Dahlbäck, B .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (01) :89-100
[53]   Factor v and thrombotic disease -: Description of a janus-faced protein [J].
Nicolaes, GAF ;
Dahlbäck, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :530-538
[54]   The crystal structure of the endothelial protein C receptor and a bound phospholipid [J].
Oganesyan, V ;
Oganesyan, N ;
Terzyan, S ;
Qu, DF ;
Dauter, Z ;
Esmon, NL ;
Esmon, CT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :24851-24854
[55]   Three-dimensional model of coagulation factor Va bound to activated protein C [J].
Pellequer, JL ;
Gale, AJ ;
Getzoff, ED ;
Griffin, JH .
THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) :849-857
[56]   Homology models of the c domains of blood coagulation factors V and VIII: A proposed membrane binding mode for FV and FVIII C2 domains [J].
Pellequer, JL ;
Gale, AJ ;
Griffin, JH ;
Getzoff, ED .
BLOOD CELLS MOLECULES AND DISEASES, 1998, 24 (21) :448-461
[57]   A molecular model for the triplicated a domains of human factor VIII based on the crystal structure of human ceruloplasmin [J].
Pemberton, S ;
Lindley, P ;
Zaitsev, V ;
Card, G ;
Tuddenham, EGD ;
KemballCook, G .
BLOOD, 1997, 89 (07) :2413-2421
[58]   The N-terminal epidermal growth factor-like domain of coagulation factor IX -: Probing its functions in the activation of factor IX and factor X with a monoclonal antibody [J].
Persson, KEM ;
Villoutreix, BO ;
Thämlitz, AM ;
Knobe, KE ;
Stenflo, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35616-35624
[59]   Structure of the C2 domain of human factor VIII at 1.5 Å resolution [J].
Pratt, KP ;
Shen, BW ;
Takeshima, K ;
Davie, EW ;
Fujikawa, K ;
Stoddard, BL .
NATURE, 1999, 402 (6760) :439-442
[60]   Protein S Gla-domain mutations causing impaired Ca2+-induced phospholipid binding and severe functional protein S deficiency [J].
Rezende, SM ;
Lane, DA ;
Mille-Baker, B ;
Samama, MM ;
Conard, J ;
Simmonds, RE .
BLOOD, 2002, 100 (08) :2812-2819